Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valentina Fausti

Showing results (11-20 of 52) with videos related to

Pageof 6
Sort By:
Contact Dermatitis|June 23, 2010
Measurement of a possible patch-testing outcome indicatorRosella Gallo, Manuela Baldari, Valentina Fausti, et al.
Journal of Bone Oncology|March 27, 2019
mTOR inhibitor and bone-targeted drugs break the vicious cycle between clear-cell renal carcinoma and osteoclasts in an in vitro co-culture modelChiara Spadazzi, Federica Recine, Laura Mercatali, et al.
Expert Review of Anticancer Therapy|June 27, 2015
Liver toxicity in colorectal cancer patients treated with first-line FOLFIRI-containing regimen: a single institution experienceBruno Vincenzi, Marco Imperatori, Antonio Picardi, et al.
BMC Research Notes|April 19, 2015
Classic Kaposi Sarcoma: to treat or not to treat?Bruno Vincenzi, Loretta D'Onofrio, Anna Maria Frezza, et al.
Oncotargets and Therapy|March 7, 2017
Update on the role of trabectedin in the treatment of intractable soft tissue sarcomasFederica Recine, Alberto Bongiovanni, Nada Riva, et al.
World Journal of Gastroenterology|March 30, 2016
Pancreatic metastasis from mycosis fungoides mimicking primary pancreatic tumorPaola Ceriolo, Valentina Fausti, Elisa Cinotti, et al.
Medicine|May 20, 2021
ALK-negative lung inflammatory myofibroblastic tumor in a young adult: A case report and literature review of molecular alterationsSilvia Angela Debonis, Alberto Bongiovanni, Federica Pieri, et al.
Pharmaceuticals (Basel, Switzerland)|June 2, 2021
Activity and Safety of Immune Checkpoint Inhibitors in Neuroendocrine Neoplasms: A Systematic Review and Meta-AnalysisAlberto Bongiovanni, Brigida Anna Maiorano, Irene Azzali, et al.
Medicine|November 18, 2017
Osteoblastic bone metastases from neuroendocrine tumor (NET) of unknown origin detected by 18fluorocholine PET/CT and its comparison with 68gallium-DOTATOC PET/CT: Case report and review of the literatureAlberto Bongiovanni, Federica Recine, Monica Celli, et al.
Cells|October 28, 2018
Characterization and Drug Sensitivity of a New High-Grade Myxofibrosarcoma Cell LineGiacomo Miserocchi, Alessandro De Vita, Laura Mercatali, et al.
Pageof 6

Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
Contact Dermatitis|June 23, 2010
Measurement of a possible patch-testing outcome indicatorRosella Gallo, Manuela Baldari, Valentina Fausti, et al.
Journal of Bone Oncology|March 27, 2019
mTOR inhibitor and bone-targeted drugs break the vicious cycle between clear-cell renal carcinoma and osteoclasts in an in vitro co-culture modelChiara Spadazzi, Federica Recine, Laura Mercatali, et al.
Expert Review of Anticancer Therapy|June 27, 2015
Liver toxicity in colorectal cancer patients treated with first-line FOLFIRI-containing regimen: a single institution experienceBruno Vincenzi, Marco Imperatori, Antonio Picardi, et al.
BMC Research Notes|April 19, 2015
Classic Kaposi Sarcoma: to treat or not to treat?Bruno Vincenzi, Loretta D'Onofrio, Anna Maria Frezza, et al.
Oncotargets and Therapy|March 7, 2017
Update on the role of trabectedin in the treatment of intractable soft tissue sarcomasFederica Recine, Alberto Bongiovanni, Nada Riva, et al.
World Journal of Gastroenterology|March 30, 2016
Pancreatic metastasis from mycosis fungoides mimicking primary pancreatic tumorPaola Ceriolo, Valentina Fausti, Elisa Cinotti, et al.
Medicine|May 20, 2021
ALK-negative lung inflammatory myofibroblastic tumor in a young adult: A case report and literature review of molecular alterationsSilvia Angela Debonis, Alberto Bongiovanni, Federica Pieri, et al.
Pharmaceuticals (Basel, Switzerland)|June 2, 2021
Activity and Safety of Immune Checkpoint Inhibitors in Neuroendocrine Neoplasms: A Systematic Review and Meta-AnalysisAlberto Bongiovanni, Brigida Anna Maiorano, Irene Azzali, et al.
Medicine|November 18, 2017
Osteoblastic bone metastases from neuroendocrine tumor (NET) of unknown origin detected by 18fluorocholine PET/CT and its comparison with 68gallium-DOTATOC PET/CT: Case report and review of the literatureAlberto Bongiovanni, Federica Recine, Monica Celli, et al.
Cells|October 28, 2018
Characterization and Drug Sensitivity of a New High-Grade Myxofibrosarcoma Cell LineGiacomo Miserocchi, Alessandro De Vita, Laura Mercatali, et al.
Pageof 6